Form 4 for PALI PALISADE BIO, INC.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-21 · accession 0001493152-24-047364 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-21 | PALI | Wei Binxian | Dir | M - OptEx | $0.00 | +388 | 855 | +83% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Comon Stock, par value $0.01 | 2024-11-21 | M | A | 388 | $0.00 | 855 | D | — | — | (F1) Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023. |